| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Alison Blenkinsopp | Q41697765 |
| Claire Anderson | Q30505588 | ||
| P2093 | author name string | Miriam Armstrong | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacy | Q614304 |
| systematic review | Q1504425 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 144-153 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Journal of Public Health | Q15754594 |
| P1476 | title | Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease | |
| P478 | volume | 25 |
| Q30828076 | 'Making the invisible visible' through alcohol screening and brief intervention in community pharmacies: an Australian feasibility study |
| Q35023598 | 10-year risk estimation for type 2 diabetes mellitus and coronary heart disease in Kuwait: a cross-sectional population-based study |
| Q53281791 | A Systematic Review of Community Pharmacists' Interventions in Reducing Major Risk Factors for Cardiovascular Disease. |
| Q38687368 | A community pharmacy-based cardiovascular risk screening service implemented in Iran |
| Q38066108 | A comparison of the application of STOPP/START to patients' drug lists with and without clinical information |
| Q36818146 | Accuracy of monitors used for blood pressure checks in English retail pharmacies: a cross-sectional observational study |
| Q34106230 | An analysis of quality of systematic reviews on pharmacist health interventions |
| Q46849299 | Analysis of primary prevention services for cardiovascular disease in Australia's community pharmacies |
| Q37543893 | Application of STOPP and START criteria: interrater reliability among pharmacists |
| Q33572577 | Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community pharmacies |
| Q33444442 | Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation |
| Q61800234 | Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? |
| Q85001042 | Clinical pharmacists and basic scientists: do patients and physicians need this collaboration? |
| Q47953865 | Community health integration through pharmacy process and ergonomics redesign (CHIPPER). |
| Q37121282 | Community pharmacy and public health in Great Britain, 1936 to 2006: how a phoenix rose from the ashes |
| Q24247372 | Community pharmacy personnel interventions for smoking cessation |
| Q42848525 | Community pharmacy service users' views and perceptions of alcohol screening and brief intervention |
| Q44838246 | Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service. |
| Q34785188 | Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program - A Markov Model |
| Q37874052 | Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review |
| Q24234308 | Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns |
| Q38498187 | Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000-2010). |
| Q48222599 | Effectiveness of pharmacist's intervention in the management of cardiovascular diseases |
| Q33685028 | Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study |
| Q60918108 | Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: a study protocol for a randomized controlled trial |
| Q35853043 | Exploring an increased role for Australian community pharmacy in mental health professional service delivery: evaluation of the literature. |
| Q92430430 | General practitioner and pharmacist collaboration: does this improve risk factors for cardiovascular disease and diabetes? A systematic review protocol |
| Q27691423 | How to promote healthy behaviours in patients? An overview of evidence for behaviour change techniques |
| Q37454961 | Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial |
| Q37390165 | Improving access to smoking cessation services for disadvantaged groups: a systematic review. |
| Q86144939 | Involvement of Sudanese community pharmacists in public health activities |
| Q60311566 | Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study |
| Q26771802 | Mapping the terrain: A conceptual schema for a mental health medication support service in community pharmacy |
| Q38205883 | Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy |
| Q37185899 | Migration as a form of workforce attrition: a nine-country study of pharmacists. |
| Q47635441 | Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review. |
| Q27315364 | Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community |
| Q55038141 | Pharmacy-based alcohol-misuse services: current perspectives. |
| Q92862953 | Primary prevention of ischaemic heart disease: populations, individuals, and health professionals |
| Q51147429 | Provision of smoking cessation services in Australian community pharmacies: a simulated patient study. |
| Q36113780 | Qualitative study on the implementation of professional pharmacy services in Australian community pharmacies using framework analysis |
| Q37763002 | Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients. |
| Q38004884 | Review of services provided by pharmacies that promote healthy living |
| Q38629187 | Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the State of Qatar |
| Q38107551 | Screening for major diseases in community pharmacies: a systematic review. |
| Q55012334 | Service provision in the wake of a new funding model for community pharmacy. |
| Q46773230 | Smoking cessation counseling in Qatar: community pharmacists' attitudes, role perceptions and practices. |
| Q90668016 | Testing the organizational theory of innovation implementation effectiveness in a community pharmacy medication management program: a hurdle regression analysis |
| Q35851247 | The Impact of Clinical Pharmacist Support on Patients Receiving Multi-drug Therapy for Coronary Heart Disease in China |
| Q30397386 | The WHO UNESCO FIP Pharmacy Education Taskforce |
| Q30397713 | The WHO UNESCO FIP Pharmacy Education Taskforce: enabling concerted and collective global action |
| Q24200923 | The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries |
| Q35137431 | The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting |
| Q38635471 | The effects of community pharmacy public health interventions on population health and health inequalities: a systematic review of reviews protocol. |
| Q92930446 | The effects of community pharmacy-delivered public health interventions on population health and health inequalities: A review of reviews |
| Q34558337 | The feasibility and acceptability of the provision of alcohol screening and brief advice in pharmacies for women accessing emergency contraception: an evaluation study |
| Q47364403 | The public's perception of the role of community pharmacists in Wales. |
| Q46455546 | The role of Sudanese community pharmacists in patients' self-care |
| Q36583618 | The roles of community pharmacists in cardiovascular disease prevention and management. |
| Q34505207 | Tobacco users' perceptions of a brief tobacco cessation intervention in community pharmacies |
| Q36225664 | What works for whom in pharmacist-led smoking cessation support: realist review. |
Search more.